Trichothecin | 6379-69-7

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 英文名称: Trichothecin
• 英文别名: [(1S,2R,7R,9R)-1,2,5-trimethyl-4-oxospiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2'-oxirane]-11-yl] (Z)-but-2-enoate
• CAS: 6379-69-7
• 化学式: C₁₉H₂₄O₅
• 分子量: 332.397
• InChiKey: LJWZOKOFCBPNAG-IZVRAYAXSA-N

物化性质

• 熔点：
  118°
• 比旋光度：
  D18 +44° (c = 1 in CHCl3)
• 沸点：
  389.51°C (rough estimate)
• 密度：
  1.1165 (rough estimate)

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  24
• 可旋转键数：
  3
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.68
• 拓扑面积：
  65.1
• 氢给体数：
  0
• 氢受体数：
  5

安全信息

• 危险等级：
  6.1(a)
• 危险品标志：
  T+
• 危险类别码：
  R26/27/28,R36/37/38
• RTECS号：
  YD0175000
• 包装等级：
  I
• 危险类别：
  6.1(a)
• 危险品运输编号：
  UN 3172

文献信息

• RIBOSOME STRUCTURE AND PROTEIN SYNTHESIS INHIBITORS
  申请人：Steitz A. Thomas

  公开号：US20050036997A1

  公开（公告）日：2005-02-17

  The invention provides methods for producing high resolution crystals of ribosomes and ribosomal subunits as well as crystals produced by such methods. The invention also provides high resolution structures of ribosomal subunits either alone or in combination with protein synthesis inhibitors. The invention provides methods for identifying ribosome-related ligands and methods for designing ligands with specific ribosome-binding properties as well as ligands that may act as protein synthesis inhibitors. Thus, the methods and compositions of the invention may be used to produce ligands that are designed to specifically kill or inhibit the growth of any target organism.

  本发明提供了生产核糖体和核糖体亚基高分辨率晶体的方法，以及由这些方法产生的晶体。该发明还提供了核糖体亚基的高分辨率结构，无论是单独还是与蛋白质合成抑制剂结合。该发明提供了用于识别与核糖体相关的配体的方法，以及设计具有特定核糖体结合性质的配体的方法，以及可能起作用为蛋白质合成抑制剂的配体。因此，本发明的方法和组合物可用于生产专门设计用于杀灭或抑制任何目标生物生长的配体。
• THREE-STEP PRETARGETING METHODS AND COMPOUNDS
  申请人：——

  公开号：US20020015705A1

  公开（公告）日：2002-02-07

  Methods, compounds, compositions and kits that relate to pretargeted delivery of diagnostic and therapeutic agents are disclosed. In particular, three-step pretargeting methods are described.

  涉及预定位递送诊断和治疗药物的方法、化合物、组合物和试剂盒已被披露。具体而言，描述了三步预定位方法。
• TF antagonist
  申请人：——

  公开号：US20040072755A1

  公开（公告）日：2004-04-15

  This invention relates to novel compounds which bind to tissue factor and mediate a cytotoxic response.

  这项发明涉及一种新型化合物，它们与组织因子结合并介导细胞毒性反应。
• Pretargeting methods and compounds
  申请人：NeoRx Corporation

  公开号：US20040241172A1

  公开（公告）日：2004-12-02

  Methods, compounds, compositions and kits that relate to pretargeted delivery of diagnostic and therapeutic agents are disclosed. In particular, methods for radiometal labeling of biotin and for improved radiohalogenation of biotin, as well as related compounds, are described. Also, clearing agents, anti-ligand-targeting moiety conjugates, target cell retention enhancing moieties and additional methods are discussed.

  本文揭示了与预定位传递诊断和治疗剂相关的方法、化合物、组合物和工具包。具体而言，描述了生物素的放射金属标记方法以及改进的生物素放射卤素化方法，以及相关化合物。同时，还讨论了清除剂、抗配体靶向基团共轭物、靶细胞保留增强基团和其他方法。
• Ribosome structure and protein synthesis inhibitors
  申请人：Steitz A. Thomas

  公开号：US20050272681A1

  公开（公告）日：2005-12-08

  The invention provides methods for producing high resolution crystals of ribosomes and ribosomal subunits as well as crystals produced by such methods. The invention also provides high resolution structures of ribosomal subunits either alone or in combination with protein synthesis inhibitors. The invention provides methods for identifying ribosome-related ligands and methods for designing ligands with specific ribosome-binding properties as well as ligands that may act as protein synthesis inhibitors. Thus, the methods and compositions of the invention may be used to produce ligands that are designed to specifically kill or inhibit the growth of any target organism.

  本发明提供了制备高分辨率核糖体和核糖体亚基晶体的方法，以及由这些方法产生的晶体。本发明还提供了核糖体亚基的高分辨率结构，无论是单独还是与蛋白质合成抑制剂结合。本发明提供了识别与核糖体相关的配体的方法，以及设计具有特定核糖体结合性质的配体的方法，以及可能作为蛋白质合成抑制剂的配体。因此，本发明的方法和组合物可用于生产旨在特异性杀死或抑制任何目标生物生长的配体。